Analytical research and development (AR&D) involves numerous processes required for drug development. AR&D includes processes such as reference standard qualification, validation of analytical methods ...
In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foundational role. From early research through to GMP ...
This field has evolved considerably through the integration of systematic design strategies, notably the incorporation of Analytical Quality by Design (AQbD) principles and robust statistical tools ...
GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...
WIXOM, Mich.--(BUSINESS WIRE)--Velesco Pharma, the expert in pharmaceutical development and clinical manufacturing, has expanded and enhanced its formulation and analytical research and development ...
The pharmaceutical industry is a pillar of global health, valued at over $1.5 trillion. Within this sector, Analytical Research and Development (AR&D) ensures drug quality, safety, and efficacy. AR&D ...
The appeal of these diverse careers often lies in the different types of impact they enable. A PhD can teach more than ...
Electrochemical sensors exploit redox reactions to convert chemical information into measurable electrical signals, making them indispensable in diverse applications ranging from biomedical ...
Respiratory diseases affect millions of people worldwide, placing a significant burden on healthcare systems and patients alike. Sunilkumar Patel, Director of Respiratory Analytical Research and ...
This module will cover fundamental principles underlying cell growth, protein expression, and upstream bioprocesses. The module will provide basic knowledge for the following modules so that all ...
The United States led global production of rare earth elements (REEs) until the mid-1990s, when China emerged as the dominant supplier. China maintained near-total control of the market until 2012.